http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2562957-T3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 |
| filingDate | 2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e9173ed29b3a69f44723d2338ab7e12 |
| publicationDate | 2016-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2562957-T3 |
| titleOfInvention | Method and composition for the treatment of diabetic ketoacidosis |
| abstract | An endothelin A antagonist for use in the treatment of diabetic ketoacidosis by administering to a mammal in need thereof a therapeutically effective amount of the endothelin A antagonist, in which the endothelin antagonist is selected from the group consisting of atrasentán, tezosentan, bosentan, darnsentan, sitaxsentán, enrasentan, BMS-207940, BMS-193884, BMS-182874, J-104132, TAK-044, BQ123, LU 135252, A-182086, TBC2576, TBC3214, PD156707 PD180988, ABT-546, ABT-627, Z1611, RPRf 18031A, SB247083, SB217242, S-Lu302872, SB209670 and mixtures thereof. |
| priorityDate | 2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 135.